APO Research
Talk to an analyst

APO RESEARCH · REPORT

Non Corticosteroid Anti-inflammatory Eyedrops

Compare research editions
View pricing & licenses

Selected research

Market Outlook & Growth Opportunities

Global Non Corticosteroid Anti-inflammatory Eyedrops Market Outlook and Growth Opportunities 2026

19 December 2025198 pages

Choose your research edition.

Industry ResearchNon Corticosteroid Anti-inflammatory Eyedrops Industry Research Report 2026130 pages · $2,950 USDIndustry Growth & TrendsGlobal Non Corticosteroid Anti-inflammatory Eyedrops Industry Growth and Trends Forecast to 2032115 pages · $3,450 USDMarket StructureGlobal Non Corticosteroid Anti-inflammatory Eyedrops Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032192 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Non Corticosteroid Anti-inflammatory Eyedrops Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Non Corticosteroid Anti-inflammatory Eyedrops Market Analysis and Forecast 2026-2032191 pages · $4,950 USD

Market perspective

The global Non Corticosteroid Anti-inflammatory Eyedrops market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a compound annual growth rate (CAGR) of % over 2026-2032.

The North America market for Non Corticosteroid Anti-inflammatory Eyedrops is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Non Corticosteroid Anti-inflammatory Eyedrops is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Non Corticosteroid Anti-inflammatory Eyedrops is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

In China, the Non Corticosteroid Anti-inflammatory Eyedrops market is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Major global companies in the Non Corticosteroid Anti-inflammatory Eyedrops market include Novartis AG, Allergan, Inc., Walgreens, Viva Opti-Free, Visine, Systane, Staples, Similasan Corporation and Rite Aid, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Non Corticosteroid Anti-inflammatory Eyedrops market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Non Corticosteroid Anti-inflammatory Eyedrops and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Non Corticosteroid Anti-inflammatory Eyedrops sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Non Corticosteroid Anti-inflammatory Eyedrops market size, projected growth trends, production technologies, key applications, and end-use industries.

Non Corticosteroid Anti-inflammatory Eyedrops Segment by Company

Novartis AG

Allergan, Inc.

Walgreens

Viva Opti-Free

Visine

Systane

Staples

Similasan Corporation

Rite Aid

Meda Pharmaceuticals Inc

Clear eyes

Cigna

Bausch & Lomb Inc

Bausch & Lomb

Alcon

Non Corticosteroid Anti-inflammatory Eyedrops Segment by Type

Diclofenac

Mugabe

Ocufen

Others

Non Corticosteroid Anti-inflammatory Eyedrops Segment by Application

Adult

Children

Non Corticosteroid Anti-inflammatory Eyedrops Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Nordic Countries

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global Non Corticosteroid Anti-inflammatory Eyedrops status and future forecast, involving, sales, revenue, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions Non Corticosteroid Anti-inflammatory Eyedrops market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify Non Corticosteroid Anti-inflammatory Eyedrops significant trends, drivers, influence factors in global and regions.

6. To analyze Non Corticosteroid Anti-inflammatory Eyedrops competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Non Corticosteroid Anti-inflammatory Eyedrops market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Non Corticosteroid Anti-inflammatory Eyedrops and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Non Corticosteroid Anti-inflammatory Eyedrops.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Non Corticosteroid Anti-inflammatory Eyedrops market, including product definition, global market growth prospects, sales value, sales volume, and average price forecasts (2021-2032).

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global Non Corticosteroid Anti-inflammatory Eyedrops industry.

Chapter 3: Detailed analysis of Non Corticosteroid Anti-inflammatory Eyedrops manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales and value of Non Corticosteroid Anti-inflammatory Eyedrops in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space, and market size of each country in the world.

Chapter 7: Sales and value of Non Corticosteroid Anti-inflammatory Eyedrops in country level. It provides sigmate data by type, and by application for each country/region.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights.

More report detail

Tables and figures
List of Tables Table 1. Non Corticosteroid Anti-inflammatory Eyedrops Industry Trends Table 2. Non Corticosteroid Anti-inflammatory Eyedrops Industry Drivers Table 3. Non Corticosteroid Anti-inflammatory Eyedrops Industry Opportunities and Challenges Table 4. Non Corticosteroid Anti-inflammatory Eyedrops Industry Restraints Table 5. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Company (US$ Million) & (2021-2026) Table 6. Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue Share by Company (2021-2026) Table 7. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Volume by Company (W Units) & (2021-2026) Table 8. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Volume Share by Company (2021-2026) Table 9. Global Non Corticosteroid Anti-inflammatory Eyedrops Average Price (US$/Unit) of Company (2021-2026) Table 10. Global Non Corticosteroid Anti-inflammatory Eyedrops Company Ranking, (2024-2026) & (USD Million) Table 11. Global Non Corticosteroid Anti-inflammatory Eyedrops Key Company Manufacturing Base & Headquarters Table 12. Global Non Corticosteroid Anti-inflammatory Eyedrops Company, Product Type & Application Table 13. Global Non Corticosteroid Anti-inflammatory Eyedrops Company Establishment Date Table 14. Global Company Market Concentration Ratio (CR5 and HHI) Table 15. Global Non Corticosteroid Anti-inflammatory Eyedrops by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on Revenue of 2025) Table 16. Mergers & Acquisitions, Expansion Table 17. Significant Companies of Diclofenac Table 18. Significant Companies of Mugabe Table 19. Significant Companies of Ocufen Table 20. Significant Companies of Others Table 21. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Volume by Type 2021 VS 2025 VS 2032 (W Units) Table 22. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Volume by Type (2021-2026) & (W Units) Table 23. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Volume by Type (2027-2032) & (W Units) Table 24. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Volume Share by Type (2021-2026) Table 25. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Volume Share by Type (2027-2032) Table 26. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value by Type 2021 VS 2025 VS 2032 (US$ Million) Table 27. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value by Type (2021-2026) & (US$ Million) Table 28. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value by Type (2027-2032) & (US$ Million) Table 29. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type (2021-2026) Table 30. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type (2027-2032) Table 31. Significant Companies of Adult Table 32. Significant Companies of Children Table 33. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Volume by Application 2021 VS 2025 VS 2032 (W Units) Table 34. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Volume by Application (2021-2026) & (W Units) Table 35. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Volume by Application (2027-2032) & (W Units) Table 36. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Volume Share by Application (2021-2026) Table 37. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Volume Share by Application (2027-2032) Table 38. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value by Application 2021 VS 2025 VS 2032 (US$ Million) Table 39. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value by Application (2021-2026) & (US$ Million) Table 40. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value by Application (2027-2032) & (US$ Million) Table 41. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application (2021-2026) Table 42. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application (2027-2032) Table 43. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Region: 2021 VS 2025 VS 2032 (W Units) Table 44. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Region (2021-2026) & (W Units) Table 45. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Region (2021-2026) Table 46. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Region (2027-2032) & (W Units) Table 47. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Region (2027-2032) Table 48. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value by Region (2021-2026) & (US$ Million) Table 50. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Region (2021-2026) Table 51. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value by Region (2027-2032) & (US$ Million) Table 52. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Region (2027-2032) Table 53. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Average Price (US$/Unit) by Region (2021-2026) Table 54. Global Non Corticosteroid Anti-inflammatory Eyedrops Market Average Price (US$/Unit) by Region (2027-2032) Table 55. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country: 2021 VS 2025 VS 2032 (W Units) Table 56. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value by Country: 2021 VS 2025 VS 2032 (US$ Million) Table 57. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2021-2026) & (W Units) Table 58. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Country (2021-2026) Table 59. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2027-2032) & (W Units) Table 60. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Country (2027-2032) Table 61. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value by Country (2021-2026) & (US$ Million) Table 62. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Market Share by Country (2021-2026) Table 63. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value by Country (2027-2032) & (US$ Million) Table 64. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Market Share by Country (2027-2032) Table 65. Novartis AG Company Information Table 66. Novartis AG Business Overview Table 67. Novartis AG Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 68. Novartis AG Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 69. Novartis AG Recent Development Table 70. Allergan, Inc. Company Information Table 71. Allergan, Inc. Business Overview Table 72. Allergan, Inc. Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 73. Allergan, Inc. Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 74. Allergan, Inc. Recent Development Table 75. Walgreens Company Information Table 76. Walgreens Business Overview Table 77. Walgreens Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 78. Walgreens Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 79. Walgreens Recent Development Table 80. Viva Opti-Free Company Information Table 81. Viva Opti-Free Business Overview Table 82. Viva Opti-Free Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 83. Viva Opti-Free Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 84. Viva Opti-Free Recent Development Table 85. Visine Company Information Table 86. Visine Business Overview Table 87. Visine Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 88. Visine Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 89. Visine Recent Development Table 90. Systane Company Information Table 91. Systane Business Overview Table 92. Systane Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 93. Systane Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 94. Systane Recent Development Table 95. Staples Company Information Table 96. Staples Business Overview Table 97. Staples Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 98. Staples Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 99. Staples Recent Development Table 100. Similasan Corporation Company Information Table 101. Similasan Corporation Business Overview Table 102. Similasan Corporation Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 103. Similasan Corporation Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 104. Similasan Corporation Recent Development Table 105. Rite Aid Company Information Table 106. Rite Aid Business Overview Table 107. Rite Aid Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 108. Rite Aid Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 109. Rite Aid Recent Development Table 110. Meda Pharmaceuticals Inc Company Information Table 111. Meda Pharmaceuticals Inc Business Overview Table 112. Meda Pharmaceuticals Inc Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 113. Meda Pharmaceuticals Inc Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 114. Meda Pharmaceuticals Inc Recent Development Table 115. Clear eyes Company Information Table 116. Clear eyes Business Overview Table 117. Clear eyes Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 118. Clear eyes Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 119. Clear eyes Recent Development Table 120. Cigna Company Information Table 121. Cigna Business Overview Table 122. Cigna Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 123. Cigna Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 124. Cigna Recent Development Table 125. Bausch & Lomb Inc Company Information Table 126. Bausch & Lomb Inc Business Overview Table 127. Bausch & Lomb Inc Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 128. Bausch & Lomb Inc Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 129. Bausch & Lomb Inc Recent Development Table 130. Bausch & Lomb Company Information Table 131. Bausch & Lomb Business Overview Table 132. Bausch & Lomb Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 133. Bausch & Lomb Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 134. Bausch & Lomb Recent Development Table 135. Alcon Company Information Table 136. Alcon Business Overview Table 137. Alcon Non Corticosteroid Anti-inflammatory Eyedrops Sales (W Units), Value (US$ Million), Price (US$/Unit) and Gross Margin (2021-2026) Table 138. Alcon Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio Table 139. Alcon Recent Development Table 140. Key Raw Materials Table 141. Raw Materials Key Suppliers Table 142. Non Corticosteroid Anti-inflammatory Eyedrops Distributors List Table 143. Non Corticosteroid Anti-inflammatory Eyedrops Customers List Table 144. Research Programs/Design for This Report Table 145. Authors List of This Report Table 146. Secondary Sources Table 147. Primary Sources List of Figures Figure 1. Non Corticosteroid Anti-inflammatory Eyedrops Product Image Figure 2. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value (2021-2032) & (US$ Million) Figure 4. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales (2021-2032) & (W Units) Figure 5. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Average Price (US$/Unit) & (2021-2032) Figure 6. Global Non Corticosteroid Anti-inflammatory Eyedrops Company Revenue Ranking in 2025 (US$ Million) Figure 7. Global Top 5 and 10 Company Market Share by Revenue in 2025 (US$ Million) Figure 8. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 9. Diclofenac Image Figure 10. Mugabe Image Figure 11. Ocufen Image Figure 12. Others Image Figure 13. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Volume by Type (2021 VS 2025 VS 2032) & (W Units) Figure 14. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Volume Share 2021 VS 2025 VS 2032 Figure 15. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Volume Share by Type (2021-2032) Figure 16. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 17. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share 2021 VS 2025 VS 2032 Figure 18. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type (2021-2032) Figure 19. Adult Image Figure 20. Children Image Figure 21. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Volume by Application (2021 VS 2025 VS 2032) & (W Units) Figure 22. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Volume Share 2021 VS 2025 VS 2032 Figure 23. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Volume Share by Application (2021-2032) Figure 24. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 25. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share 2021 VS 2025 VS 2032 Figure 26. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application (2021-2032) Figure 27. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Region: 2021 VS 2025 VS 2032 (W Units) Figure 28. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Market Share by Region: 2021 VS 2025 VS 2032 Figure 29. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Comparison by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 30. Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Region: 2021 VS 2025 VS 2032 Figure 31. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales Value (2021-2032) & (US$ Million) Figure 32. North America Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Country (%), 2025 VS 2032 Figure 33. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales Value (2021-2032) & (US$ Million) Figure 34. Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Country (%), 2025 VS 2032 Figure 35. Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales Value (2021-2032) & (US$ Million) Figure 36. Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Country (%), 2025 VS 2032 Figure 37. South America Non Corticosteroid Anti-inflammatory Eyedrops Sales Value (2021-2032) & (US$ Million) Figure 38. South America Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Country (%), 2025 VS 2032 Figure 39. Middle East & Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales Value (2021-2032) & (US$ Million) Figure 40. Middle East & Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Country (%), 2025 VS 2032 Figure 41. USA Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 42. USA Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 43. USA Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 44. Canada Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 45. Canada Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 46. Canada Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 47. Mexico Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 48. Mexico Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 49. Mexico Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 50. Germany Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 51. Germany Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 52. Germany Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 53. France Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 54. France Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 55. France Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 56. U.K. Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 57. U.K. Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 58. U.K. Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 59. Italy Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 60. Italy Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 61. Italy Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 62. Spain Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 63. Spain Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 64. Spain Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 65. Russia Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 66. Russia Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 67. Russia Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 68. Netherlands Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 69. Netherlands Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 70. Netherlands Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 71. Nordic Countries Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 72. Nordic Countries Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 73. Nordic Countries Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 74. China Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 75. China Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 76. China Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 77. Japan Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 78. Japan Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 79. Japan Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 80. South Korea Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 81. South Korea Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 82. South Korea Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 83. India Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 84. India Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 85. India Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 86. Australia Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 87. Australia Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 88. Australia Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 89. Southeast Asia Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 90. Southeast Asia Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 91. Southeast Asia Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 92. Brazil Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 93. Brazil Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 94. Brazil Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 95. Argentina Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 96. Argentina Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 97. Argentina Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 98. Chile Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 99. Chile Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 100. Chile Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 101. Colombia Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 102. Colombia Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 103. Colombia Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 104. Peru Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 105. Peru Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 106. Peru Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 107. Saudi Arabia Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 108. Saudi Arabia Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 109. Saudi Arabia Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 110. Israel Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 111. Israel Arabia Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 112. Israel Arabia Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 113. UAE Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 114. UAE Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 115. UAE Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 116. Turkey Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 117. Turkey Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 118. Turkey Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 119. Iran Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 120. Iran Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 121. Iran Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 122. Egypt Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032) & (US$ Million) Figure 123. Egypt Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032 & (%) Figure 124. Egypt Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032 & (%) Figure 125. Non Corticosteroid Anti-inflammatory Eyedrops Value Chain Figure 126. Manufacturing Cost Structure Figure 127. Non Corticosteroid Anti-inflammatory Eyedrops Sales Mode & Process Figure 128. Direct Comparison with Distribution Share Figure 129. Distributors Profiles Figure 130. Years Considered Figure 131. Research Process Figure 132. Key Executives Interviewed

Scope & coverage.

Types
  • Diclofenac
  • Mugabe
  • Ocufen
  • Others
Applications
  • Adult
  • Children
Companies covered
  • Novartis AG
  • Allergan, Inc.
  • Walgreens
  • Viva Opti-Free
  • Visine
  • Systane
  • Staples
  • Similasan Corporation
  • Rite Aid
  • Meda Pharmaceuticals Inc
  • Clear eyes
  • Cigna
  • Bausch & Lomb Inc
  • Bausch & Lomb
  • Alcon

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value (2021-2032)
  4. 1.2.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Volume (2021-2032)
  5. 1.2.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Average Price (2021-2032)
  6. 1.3 Assumptions and Limitations
  7. 1.4 Study Goals and Objectives
2 Non Corticosteroid Anti-inflammatory Eyedrops Market Dynamics
  1. 2.1 Non Corticosteroid Anti-inflammatory Eyedrops Industry Trends
  2. 2.2 Non Corticosteroid Anti-inflammatory Eyedrops Industry Drivers
  3. 2.3 Non Corticosteroid Anti-inflammatory Eyedrops Industry Opportunities and Challenges
  4. 2.4 Non Corticosteroid Anti-inflammatory Eyedrops Industry Restraints
3 Non Corticosteroid Anti-inflammatory Eyedrops Market by Company
  1. 3.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Company Revenue Ranking in 2025
  2. 3.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Revenue by Company (2021-2026)
  3. 3.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Volume by Company (2021-2026)
  4. 3.4 Global Non Corticosteroid Anti-inflammatory Eyedrops Average Price by Company (2021-2026)
  5. 3.5 Global Non Corticosteroid Anti-inflammatory Eyedrops Company Ranking (2024-2026)
  6. 3.6 Global Non Corticosteroid Anti-inflammatory Eyedrops Company Manufacturing Base and Headquarters
  7. 3.7 Global Non Corticosteroid Anti-inflammatory Eyedrops Company Product Type and Application
  8. 3.8 Global Non Corticosteroid Anti-inflammatory Eyedrops Company Establishment Date
  9. 3.9 Market Competitive Analysis
  10. 3.9.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Market Concentration Ratio (CR5 and HHI)
  11. 3.9.2 Global Top 5 and 10 Company Market Share by Revenue in 2025
  12. 3.9.3 2025 Non Corticosteroid Anti-inflammatory Eyedrops Tier 1, Tier 2, and Tier 3 Companies
  13. 3.10 Mergers and Acquisitions Expansion
4 Non Corticosteroid Anti-inflammatory Eyedrops Market by Type
  1. 4.1 Non Corticosteroid Anti-inflammatory Eyedrops Type Introduction
  2. 4.1.1 Diclofenac
  3. 4.1.2 Mugabe
  4. 4.1.3 Ocufen
  5. 4.1.4 Others
  6. 4.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Volume by Type
  7. 4.2.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Volume by Type (2021 VS 2025 VS 2032)
  8. 4.2.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Volume by Type (2021-2032)
  9. 4.2.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Volume Share by Type (2021-2032)
  10. 4.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value by Type
  11. 4.3.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value by Type (2021 VS 2025 VS 2032)
  12. 4.3.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value by Type (2021-2032)
  13. 4.3.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type (2021-2032)
5 Non Corticosteroid Anti-inflammatory Eyedrops Market by Application
  1. 5.1 Non Corticosteroid Anti-inflammatory Eyedrops Application Introduction
  2. 5.1.1 Adult
  3. 5.1.2 Children
  4. 5.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Volume by Application
  5. 5.2.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Volume by Application (2021 VS 2025 VS 2032)
  6. 5.2.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Volume by Application (2021-2032)
  7. 5.2.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Volume Share by Application (2021-2032)
  8. 5.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value by Application
  9. 5.3.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value by Application (2021 VS 2025 VS 2032)
  10. 5.3.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value by Application (2021-2032)
  11. 5.3.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application (2021-2032)
6 Non Corticosteroid Anti-inflammatory Eyedrops Regional Sales and Value Analysis
  1. 6.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Region (2021-2032)
  3. 6.2.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Region: 2021-2026
  4. 6.2.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Region (2027-2032)
  5. 6.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value by Region: 2021 VS 2025 VS 2032
  6. 6.4 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value by Region (2021-2032)
  7. 6.4.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value by Region: 2021-2026
  8. 6.4.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value by Region (2027-2032)
  9. 6.5 Global Non Corticosteroid Anti-inflammatory Eyedrops Market Price Analysis by Region (2021-2026)
  10. 6.6 North America
  11. 6.6.1 North America Non Corticosteroid Anti-inflammatory Eyedrops Sales Value (2021-2032)
  12. 6.6.2 North America Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Country, 2025 VS 2032
  13. 6.7 Europe
  14. 6.7.1 Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales Value (2021-2032)
  15. 6.7.2 Europe Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Country, 2025 VS 2032
  16. 6.8 Asia-Pacific
  17. 6.8.1 Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales Value (2021-2032)
  18. 6.8.2 Asia-Pacific Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Country, 2025 VS 2032
  19. 6.9 South America
  20. 6.9.1 South America Non Corticosteroid Anti-inflammatory Eyedrops Sales Value (2021-2032)
  21. 6.9.2 South America Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Country, 2025 VS 2032
  22. 6.10 Middle East & Africa
  23. 6.10.1 Middle East & Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales Value (2021-2032)
  24. 6.10.2 Middle East & Africa Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Country, 2025 VS 2032
7 Non Corticosteroid Anti-inflammatory Eyedrops Country-level Sales and Value Analysis
  1. 7.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country: 2021 VS 2025 VS 2032
  2. 7.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value by Country: 2021 VS 2025 VS 2032
  3. 7.3 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2021-2032)
  4. 7.3.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2021-2026)
  5. 7.3.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales by Country (2027-2032)
  6. 7.4 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value by Country (2021-2032)
  7. 7.4.1 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value by Country (2021-2026)
  8. 7.4.2 Global Non Corticosteroid Anti-inflammatory Eyedrops Sales Value by Country (2027-2032)
  9. 7.5 USA
  10. 7.5.1 USA Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032)
  11. 7.5.2 USA Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032
  12. 7.5.3 USA Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032
  13. 7.6 Canada
  14. 7.6.1 Canada Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032)
  15. 7.6.2 Canada Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032
  16. 7.6.3 Canada Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032
  17. 7.7 Mexico
  18. 7.6.1 Mexico Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032)
  19. 7.6.2 Mexico Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032
  20. 7.6.3 Mexico Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032
  21. 7.8 Germany
  22. 7.8.1 Germany Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032)
  23. 7.8.2 Germany Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032
  24. 7.8.3 Germany Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032
  25. 7.9 France
  26. 7.9.1 France Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032)
  27. 7.9.2 France Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032
  28. 7.9.3 France Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032
  29. 7.10 U.K.
  30. 7.10.1 U.K. Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032)
  31. 7.10.2 U.K. Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032
  32. 7.10.3 U.K. Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032
  33. 7.11 Italy
  34. 7.11.1 Italy Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032)
  35. 7.11.2 Italy Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032
  36. 7.11.3 Italy Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032
  37. 7.12 Spain
  38. 7.12.1 Spain Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032)
  39. 7.12.2 Spain Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032
  40. 7.12.3 Spain Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032
  41. 7.13 Russia
  42. 7.13.1 Russia Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032)
  43. 7.13.2 Russia Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032
  44. 7.13.3 Russia Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032
  45. 7.14 Netherlands
  46. 7.14.1 Netherlands Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032)
  47. 7.14.2 Netherlands Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032
  48. 7.14.3 Netherlands Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032
  49. 7.15 Nordic Countries
  50. 7.15.1 Nordic Countries Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032)
  51. 7.15.2 Nordic Countries Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032
  52. 7.15.3 Nordic Countries Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032
  53. 7.16 China
  54. 7.16.1 China Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032)
  55. 7.16.2 China Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032
  56. 7.16.3 China Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032
  57. 7.17 Japan
  58. 7.17.1 Japan Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032)
  59. 7.17.2 Japan Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032
  60. 7.17.3 Japan Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032
  61. 7.18 South Korea
  62. 7.18.1 South Korea Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032)
  63. 7.18.2 South Korea Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032
  64. 7.18.3 South Korea Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032
  65. 7.19 India
  66. 7.19.1 India Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032)
  67. 7.19.2 India Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032
  68. 7.19.3 India Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032
  69. 7.20 Australia
  70. 7.20.1 Australia Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032)
  71. 7.20.2 Australia Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032
  72. 7.20.3 Australia Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032
  73. 7.21 Southeast Asia
  74. 7.21.1 Southeast Asia Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032)
  75. 7.21.2 Southeast Asia Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032
  76. 7.21.3 Southeast Asia Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032
  77. 7.22 Brazil
  78. 7.22.1 Brazil Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032)
  79. 7.22.2 Brazil Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032
  80. 7.22.3 Brazil Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032
  81. 7.23 Argentina
  82. 7.23.1 Argentina Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032)
  83. 7.23.2 Argentina Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032
  84. 7.23.3 Argentina Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032
  85. 7.24 Chile
  86. 7.24.1 Chile Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032)
  87. 7.24.2 Chile Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032
  88. 7.24.3 Chile Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032
  89. 7.25 Colombia
  90. 7.25.1 Colombia Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032)
  91. 7.25.2 Colombia Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032
  92. 7.25.3 Colombia Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032
  93. 7.26 Peru
  94. 7.26.1 Peru Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032)
  95. 7.26.2 Peru Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032
  96. 7.26.3 Peru Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032
  97. 7.27 Saudi Arabia
  98. 7.27.1 Saudi Arabia Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032)
  99. 7.27.2 Saudi Arabia Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032
  100. 7.27.3 Saudi Arabia Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032
  101. 7.28 Israel
  102. 7.28.1 Israel Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032)
  103. 7.28.2 Israel Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032
  104. 7.28.3 Israel Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032
  105. 7.29 UAE
  106. 7.29.1 UAE Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032)
  107. 7.29.2 UAE Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032
  108. 7.29.3 UAE Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032
  109. 7.30 Turkey
  110. 7.30.1 Turkey Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032)
  111. 7.30.2 Turkey Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032
  112. 7.30.3 Turkey Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032
  113. 7.31 Iran
  114. 7.31.1 Iran Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032)
  115. 7.31.2 Iran Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032
  116. 7.31.3 Iran Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032
  117. 7.32 Egypt
  118. 7.32.1 Egypt Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Growth Rate (2021-2032)
  119. 7.32.2 Egypt Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Type, 2025 VS 2032
  120. 7.32.3 Egypt Non Corticosteroid Anti-inflammatory Eyedrops Sales Value Share by Application, 2025 VS 2032
8 Company Profiles
  1. 8.1 Novartis AG
  2. 8.1.1 Novartis AG Company Information
  3. 8.1.2 Novartis AG Business Overview
  4. 8.1.3 Novartis AG Non Corticosteroid Anti-inflammatory Eyedrops Sales, Value and Gross Margin (2021-2026)
  5. 8.1.4 Novartis AG Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  6. 8.1.5 Novartis AG Recent Developments
  7. 8.2 Allergan, Inc.
  8. 8.2.1 Allergan, Inc. Company Information
  9. 8.2.2 Allergan, Inc. Business Overview
  10. 8.2.3 Allergan, Inc. Non Corticosteroid Anti-inflammatory Eyedrops Sales, Value and Gross Margin (2021-2026)
  11. 8.2.4 Allergan, Inc. Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  12. 8.2.5 Allergan, Inc. Recent Developments
  13. 8.3 Walgreens
  14. 8.3.1 Walgreens Company Information
  15. 8.3.2 Walgreens Business Overview
  16. 8.3.3 Walgreens Non Corticosteroid Anti-inflammatory Eyedrops Sales, Value and Gross Margin (2021-2026)
  17. 8.3.4 Walgreens Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  18. 8.3.5 Walgreens Recent Developments
  19. 8.4 Viva Opti-Free
  20. 8.4.1 Viva Opti-Free Company Information
  21. 8.4.2 Viva Opti-Free Business Overview
  22. 8.4.3 Viva Opti-Free Non Corticosteroid Anti-inflammatory Eyedrops Sales, Value and Gross Margin (2021-2026)
  23. 8.4.4 Viva Opti-Free Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  24. 8.4.5 Viva Opti-Free Recent Developments
  25. 8.5 Visine
  26. 8.5.1 Visine Company Information
  27. 8.5.2 Visine Business Overview
  28. 8.5.3 Visine Non Corticosteroid Anti-inflammatory Eyedrops Sales, Value and Gross Margin (2021-2026)
  29. 8.5.4 Visine Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  30. 8.5.5 Visine Recent Developments
  31. 8.6 Systane
  32. 8.6.1 Systane Company Information
  33. 8.6.2 Systane Business Overview
  34. 8.6.3 Systane Non Corticosteroid Anti-inflammatory Eyedrops Sales, Value and Gross Margin (2021-2026)
  35. 8.6.4 Systane Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  36. 8.6.5 Systane Recent Developments
  37. 8.7 Staples
  38. 8.7.1 Staples Company Information
  39. 8.7.2 Staples Business Overview
  40. 8.7.3 Staples Non Corticosteroid Anti-inflammatory Eyedrops Sales, Value and Gross Margin (2021-2026)
  41. 8.7.4 Staples Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  42. 8.7.5 Staples Recent Developments
  43. 8.8 Similasan Corporation
  44. 8.8.1 Similasan Corporation Company Information
  45. 8.8.2 Similasan Corporation Business Overview
  46. 8.8.3 Similasan Corporation Non Corticosteroid Anti-inflammatory Eyedrops Sales, Value and Gross Margin (2021-2026)
  47. 8.8.4 Similasan Corporation Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  48. 8.8.5 Similasan Corporation Recent Developments
  49. 8.9 Rite Aid
  50. 8.9.1 Rite Aid Company Information
  51. 8.9.2 Rite Aid Business Overview
  52. 8.9.3 Rite Aid Non Corticosteroid Anti-inflammatory Eyedrops Sales, Value and Gross Margin (2021-2026)
  53. 8.9.4 Rite Aid Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  54. 8.9.5 Rite Aid Recent Developments
  55. 8.10 Meda Pharmaceuticals Inc
  56. 8.10.1 Meda Pharmaceuticals Inc Company Information
  57. 8.10.2 Meda Pharmaceuticals Inc Business Overview
  58. 8.10.3 Meda Pharmaceuticals Inc Non Corticosteroid Anti-inflammatory Eyedrops Sales, Value and Gross Margin (2021-2026)
  59. 8.10.4 Meda Pharmaceuticals Inc Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  60. 8.10.5 Meda Pharmaceuticals Inc Recent Developments
  61. 8.11 Clear eyes
  62. 8.11.1 Clear eyes Company Information
  63. 8.11.2 Clear eyes Business Overview
  64. 8.11.3 Clear eyes Non Corticosteroid Anti-inflammatory Eyedrops Sales, Value and Gross Margin (2021-2026)
  65. 8.11.4 Clear eyes Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  66. 8.11.5 Clear eyes Recent Developments
  67. 8.12 Cigna
  68. 8.12.1 Cigna Company Information
  69. 8.12.2 Cigna Business Overview
  70. 8.12.3 Cigna Non Corticosteroid Anti-inflammatory Eyedrops Sales, Value and Gross Margin (2021-2026)
  71. 8.12.4 Cigna Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  72. 8.12.5 Cigna Recent Developments
  73. 8.13 Bausch & Lomb Inc
  74. 8.13.1 Bausch & Lomb Inc Company Information
  75. 8.13.2 Bausch & Lomb Inc Business Overview
  76. 8.13.3 Bausch & Lomb Inc Non Corticosteroid Anti-inflammatory Eyedrops Sales, Value and Gross Margin (2021-2026)
  77. 8.13.4 Bausch & Lomb Inc Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  78. 8.13.5 Bausch & Lomb Inc Recent Developments
  79. 8.14 Bausch & Lomb
  80. 8.14.1 Bausch & Lomb Company Information
  81. 8.14.2 Bausch & Lomb Business Overview
  82. 8.14.3 Bausch & Lomb Non Corticosteroid Anti-inflammatory Eyedrops Sales, Value and Gross Margin (2021-2026)
  83. 8.14.4 Bausch & Lomb Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  84. 8.14.5 Bausch & Lomb Recent Developments
  85. 8.15 Alcon
  86. 8.15.1 Alcon Company Information
  87. 8.15.2 Alcon Business Overview
  88. 8.15.3 Alcon Non Corticosteroid Anti-inflammatory Eyedrops Sales, Value and Gross Margin (2021-2026)
  89. 8.15.4 Alcon Non Corticosteroid Anti-inflammatory Eyedrops Product Portfolio
  90. 8.15.5 Alcon Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Non Corticosteroid Anti-inflammatory Eyedrops Value Chain Analysis
  2. 9.1.1 Non Corticosteroid Anti-inflammatory Eyedrops Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Non Corticosteroid Anti-inflammatory Eyedrops Sales Mode & Process
  6. 9.2 Non Corticosteroid Anti-inflammatory Eyedrops Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Non Corticosteroid Anti-inflammatory Eyedrops Distributors
  9. 9.2.3 Non Corticosteroid Anti-inflammatory Eyedrops Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,250USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst